On 2025-05-08, Xeris Biopharma Holdings, Inc. (XERS) announced earnings per share of $-0.06 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.07.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.03 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.07 | $-0.06 |
| 2025-03-06 | 2024-12-31 | $-0.07 | $-0.03 |
| 2024-11-08 | 2024-09-30 | $-0.09 | $-0.06 |
| 2024-08-08 | 2024-06-30 | $-0.11 | $-0.10 |
| 2024-05-09 | 2024-03-31 | $-0.12 | $-0.14 |
| 2024-03-06 | 2023-12-31 | $-0.09 | $-0.10 |
| 2023-11-09 | 2023-09-30 | $-0.12 | $-0.09 |
| 2023-08-08 | 2023-06-30 | $-0.13 | $-0.14 |
| 2023-05-09 | 2023-03-31 | $-0.17 | $-0.12 |
| 2023-03-08 | 2022-12-31 | $-0.16 | $-0.10 |
| 2022-11-09 | 2022-09-30 | $-0.17 | $-0.14 |
| 2022-08-10 | 2022-06-30 | $-0.23 | $-0.19 |
| 2022-05-11 | 2022-03-31 | $-0.24 | $-0.25 |
| 2022-03-10 | 2021-12-31 | $-0.21 | $-0.42 |
| 2021-11-10 | 2021-09-30 | $-0.37 | $-0.36 |
| 2021-08-05 | 2021-06-30 | $-0.31 | $-0.41 |
| 2021-05-13 | 2021-03-31 | $-0.31 | $-0.30 |
| 2021-03-09 | 2020-12-31 | $-0.39 | $-0.41 |
| 2020-11-09 | 2020-09-30 | $-0.54 | $-0.35 |
| 2020-08-10 | 2020-06-30 | $-0.71 | $-0.63 |
| 2020-05-07 | 2020-03-31 | $-0.92 | $-0.89 |
| 2020-03-11 | 2019-12-31 | $-1.24 | $-1.23 |
| 2019-11-07 | 2019-09-30 | $-1.26 | $-1.22 |
| 2019-08-06 | 2019-06-30 | $-0.97 | $-1.28 |
| 2019-05-09 | 2019-03-31 | $-0.83 | $-1.07 |
| 2019-03-06 | 2018-12-31 | $-1.04 | $-0.98 |
| 2018-11-07 | 2018-09-30 | $-0.84 | $-0.71 |
| 2018-08-13 | 2018-06-30 | $-0.87 | $-3.07 |